| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Jun―24 |
Реконвалесценти після COVID-19 та ХОЗЛ: особливості імунної реактивності","Convalescents After COVID-19 and COPD: Peculiarities Of The Immune Reactivity |
О. І. Лемко, Н. В. Вантюх, Д. В. Решетар, С. В. Лукащук |
| 2 |
[GO] |
2026―Jun―24 |
Шляхи покращення діагностики та лікування пацієнтів з бронхообструктивною патологією на основі аналізу причин смертності Доцільність застосування антикоагулянтної терапії в після-гострому періоді коронавірусної хвороби (COVID-19)","Ways of the Diagnosis and Treatment of Patients with Bronchoobstructive Pathology Improvement Based on the Analysis of the Main Causes of Mortality |
Д. В. Добрянський, А. Д. Бабич, А. А. Кононенко, В. П. Король, О. Ю. Радецька, П. Ф. Дудка, et al. (+2) І. П. Тарченко, О. М. Тарасенко |
| 3 |
[GO] |
2026―Mrz―26 |
Особливості імунної реактивності у реконвалесцентів після перенесеного COVID-19 |
Н. В. Вантюх, О. І. Лемко, Д. В. Решетар |
| 4 |
[GO] |
2026―Mrz―25 |
Доцільність застосування антикоагулянтної терапії в після-гострому періоді коронавірусної хвороби (COVID-19) |
T. Pertseva, L. Konopkina, N. Habshydze, O. Myronenko, Y. Huba, M. Krykhtina, et al. (+2) K. Rybalka, L. Botvinikova |
| 5 |
[GO] |
2025―Dez―23 |
Features of Uncontrolled Course and Exacerbations of the Bronchial Asthma in the Post-Pandemic COVID-19 Period in the Wartime Conditions |
M. I. Lynnyk, V. I. Ignatieva, M. O. Polianska, S. G. Opimakh, S. M. Мoskalenko |
| 6 |
[GO] |
2024―Dez―17 |
The Dynamics of the Frequency of Positive Tests with Anesthetics in Children with an Allergy History During the COVID-19 Epidemic and Martial Law |
Yu. O. Matviienko, V. M. Zhadan, O. R. Panasiukova, S. G. Yasir |
| 7 |
[GO] |
2024―Sep―20 |
Treatment Technology for Patients with Bronchial Asthma who Have Had COVID-19 |
Yu. I. Feshchenko, M. O. Polianska, G. L. Gumeniuk, V. I. Ignatieva, S. G. Opimakh, I. V. Zvol, et al. (+5) S. M. Moskalenko, N. A. Vlasova, I. V. Chumak, L. A. Halai, O. L. Kovaliova |
| 8 |
[GO] |
2024―Sep―20 |
Immunorehabilitation of Patients after COVID-19: Possibilities of Haloaerosoltherapy |
N. V. Vantiukh, O. I. Lemko, D. V. Reshetar |
| 9 |
[GO] |
2024―Sep―20 |
Erythrocyte Sedimentation Reaction as a Marker af Immune-Mediated Disorders after Coronavirus Infection in Patients with Pulmonary Tuberculosis |
Yu. O. Matviienko, V. M. Zhadan, O. R. Panasiukova, S. G. Yasir |
| 10 |
[GO] |
2024―Jun―25 |
Side Effects of Modern Chemical Disinfectants and Antiseptics. Part 1. The COVID-19 Pandemic as a Trigger of Non-Allergic and Allergic Effects on the Health of the Population |
V. M. Britsun, I. V. Popova, S. A. Kovaleva, T. V. Petrenko |
| 11 |
[GO] |
2024―Mrz―25 |
Some Peculiarities of the Endocrine Status in Convalescents After COVID-19 and its Changes Under the Influence of Recovery Treatment |
O. I. Lemko, N. V. Vantiukh, D. V. D. V. Reshetar |
| 12 |
[GO] |
2024―Mrz―25 |
Clinical and Pharmacoeconomic Aspects of Treatment of Patients with Mild COVID-19 and the Presence of Risk Factors for the Progression of the Disease |
O. K. Yakovenko, R. E. Sukhin, G. B. Kapitain, O. Ya. Dzyublik, V. A. Yanchik, N.V. Surtaeva |
| 13 |
[GO] |
2023―Dez―21 |
Respiratory System Functional Status in Patients with Dyspnea who have Experienced Non-Hospital Acquired Pneumonia Associated with COVID-19 |
L. I. Konopkina, O. O. Shchudro |
| 14 |
[GO] |
2023―Dez―21 |
Dependence of Endothelin-1 Level in Patients Survived Community-Acquired Pneumonia Associated with COVID-19 on the Features of Acute and Post-Acute Periods |
T. O. Pertseva, N. O. Habshydze |
| 15 |
[GO] |
2023―Mrz―23 |
Peculiarities of Immune Reactivity in Convalescents After COVID-19 |
N. V. Vantiukh, O. I. Lemko, D. V. Reshetar |
| 16 |
[GO] |
2022―Dez―09 |
Mixed Cryoglobulinemia Syndrome: Features of the Clinical Course and Treatment. Literature Review and Description of a Clinical Case Associated with COVID-19 |
V. V. Tsaryk |
| 17 |
[GO] |
2022―Dez―09 |
COVID-19 and Post-covid syndrome in children with bronchial asthma |
О. О. Rechkina, S. M. Rudenko, V. O. Stryzh |
| 18 |
[GO] |
2022―Sep―27 |
Comorbidity in patients with Bronchial Asthma and Risks of Severe covid-19 |
Yu. I. Feshchenko, L. O. Iashyna, M. O. Polianska, G. L. Gumeniuk, V. I. Ignatieva, S. G. Opimakh, et al. (+2) S. M. Moskalenko, I. V. Zvol |
| 19 |
[GO] |
2022―Sep―27 |
Consequences of Acute Respiratory Infection COVID-19 and their Impact on the Course of Chronic Bronchopulmonary Diseases in Children |
V. O. Stryzh |
| 20 |
[GO] |
2022―Sep―27 |
Features of the Coronavirus Disease (COVID-19) in Patients with Asthma |
N. A. Sanina, M. S. Yekhanin |
| 21 |
[GO] |
2022―Apr―06 |
Peculiarities of Viral Etiology (COVID-19) Community-aquired Pneumonia in Patients with Bronchial Asthma |
М. І. Lynnyk, L. A. Iashyna, V. І. Іgnatieva, G. L. Gumeniuk, S. G. Opimakh, M. A. Polianska, et al. (+5) I. V. Zvol, S. M. Moskalenko, I. V. Chumak, L. A. Halai, N. A. Vlasova |
| 22 |
[GO] |
2022―Apr―06 |
Rehabilitation of Patients with COVID-19 Using a Complex of Amino Acids, Vitamins and Microelements |
Т. V. Т. V. Bezditko, І. V. Novikova, G. V. Yeryomenko, V. V. Kozar, Т. V. Myzhyrytska |
| 23 |
[GO] |
2021―Dez―29 |
VENTILATION AND DIFFUSIONAL DISORDERS IN PERSONS AFTER COMMUNITYACQUIRED PNEUMONIA, ASSOCIATED WITH CORONAVIRUS DISEASE (COVID-19). POSSIBILITIES OF INHALATION THERAPY |
T. O. Pertseva, L. I. Konopkina, K. O. Bielosludtseva, O. O. Shchudro, K. V. Fuhol |
| 24 |
[GO] |
2021―Okt―06 |
INHALED CORTICOSTEROIDS IN THE TREATMENT OF PATIENTS WITH COVID-19 |
S. V. Zaikov |
| 25 |
[GO] |
2021―Okt―06 |
COVID-19 TREATMENT GUIDELINES FOR HOSPITALIZED PATIENTS AT ST. VINCENT’S MEDICAL CENTER, A LICENSED 473-BED COMMUNITY TEACHING HOSPITAL WITH A LEVEL II TRAUMA CENTER IN THE UNITED STATES |
Valeriia Klymenko, Haritha Mopuru, Arsalan Alvi, Maria Morel, Nataliia Dyatlova, Michael Elias, David Regelmann |
| 26 |
[GO] |
2021―Jun―23 |
CURRENT ISSUES OF BRONCHIAL ASTHMA 2021: WORLD ASTHMA DAY AND THE IMPACT OF THE COVID-19 PANDEMIC |
G. L. Gumeniuk, V. I. Ignatieva, S. G. Opimakh |
| 27 |
[GO] |
2021―Apr―14 |
CORONAVIRUS INFECTION: TYPES, CLINICAL FEATURES, WAYS OF PREVENTION |
O. L. Bororova |
| 28 |
[GO] |
2020―Dez―23 |
NEBULIZER THERAPY: PECULIARITIES OF ITS USAGE DURING СOVID-19 PANDEMICS ACCORDING TO THE POINT OF VIEW OF GLOBAL INITIATIVES |
M. M. Ostrovsky |
| 29 |
[GO] |
2020―Jun―24 |
BRITISH RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ALLERGIC DISEASES DURING THE COVID-19 PANDEMIC |
A. A. Nakonechna |
